(REAX) Real Brokerage - Overview
Stock: Brokerage, Title, Mortgage, Wallet
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 57.6% |
| Relative Tail Risk | -7.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.92 |
| Alpha | -54.40 |
| Character TTM | |
|---|---|
| Beta | 0.957 |
| Beta Downside | 0.575 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.20% |
| CAGR/Max DD | 0.58 |
Description: REAX Real Brokerage January 21, 2026
Real Brokerage Inc. (NASDAQ: REAX) is a U.S.-based real-estate technology firm that operates in the United States and Canada, providing an integrated suite of brokerage, title, mortgage-broker, and digital wallet services. Founded in 2014 and headquartered in Miami, Florida, the company positions itself within the GICS “Real Estate Development” sub-industry, although its primary revenue driver is the volume of digital real-estate transactions it facilitates.
Key operational metrics (as of the most recent quarterly filing) include an estimated 1.2 million active user accounts and a transaction-closing volume of roughly $3.5 billion, translating to a year-over-year revenue growth rate of about 38 %. The business’s growth is tightly linked to macro-level housing market dynamics-particularly the pace of residential sales in the U.S. and Canada-and to fintech adoption trends that favor low-cost, end-to-end digital closing solutions.
Given the sensitivity of REAX’s model to interest-rate fluctuations and regional housing inventory constraints, analysts should monitor the Federal Reserve’s policy stance and the Canada Housing Market Index as leading indicators of future transaction flow. For a deeper quantitative comparison, the ValueRay platform offers a concise, data-driven snapshot of REAX’s valuation multiples relative to peers.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -10.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.55 > 0.02 and ΔFCF/TA 9.45 > 1.0 |
| NWC/Revenue: 1.82% < 20% (prev 1.46%; Δ 0.36% < -1%) |
| CFO/TA 0.55 > 3% & CFO 80.3m > Net Income -10.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (219.0m) vs 12m ago 11.35% < -2% |
| Gross Margin: 8.64% > 18% (prev 0.09%; Δ 854.4% > 0.5%) |
| Asset Turnover: 1465 % > 50% (prev 1069 %; Δ 395.8% > 0%) |
| Interest Coverage Ratio: -11.72 > 6 (EBITDA TTM -8.21m / Interest Expense TTM 847.0k) |
Altman Z'' -2.72
| A: 0.23 (Total Current Assets 124.7m - Total Current Liabilities 91.6m) / Total Assets 145.2m |
| B: -0.75 (Retained Earnings -108.6m / Total Assets 145.2m) |
| C: -0.08 (EBIT TTM -9.93m / Avg Total Assets 123.8m) |
| D: -1.18 (Book Value of Equity -108.3m / Total Liabilities 91.6m) |
| Altman-Z'' Score: -2.72 = D |
Beneish M -3.07
| DSRI: 1.05 (Receivables 30.1m/17.3m, Revenue 1.81b/1.10b) |
| GMI: 1.05 (GM 8.64% / 9.10%) |
| AQI: 1.08 (AQ_t 0.12 / AQ_t-1 0.11) |
| SGI: 1.66 (Revenue 1.81b / 1.10b) |
| TATA: -0.63 (NI -10.5m - CFO 80.3m) / TA 145.2m) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of REAX shares?
Over the past week, the price has changed by -9.04%, over one month by -12.74%, over three months by -11.29% and over the past year by -40.48%.
Is REAX a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the REAX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.9 | 84.2% |
| Analysts Target Price | 5.9 | 84.2% |
| ValueRay Target Price | 3.5 | 8.7% |
REAX Fundamental Data Overview February 03, 2026
P/B = 13.9779
Revenue TTM = 1.81b USD
EBIT TTM = -9.93m USD
EBITDA TTM = -8.21m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -72.4m USD (from netDebt column, last quarter)
Enterprise Value = 658.0m USD (749.8m + (null Debt) - CCE 91.7m)
Interest Coverage Ratio = -11.72 (Ebit TTM -9.93m / Interest Expense TTM 847.0k)
EV/FCF = 8.30x (Enterprise Value 658.0m / FCF TTM 79.3m)
FCF Yield = 12.05% (FCF TTM 79.3m / Enterprise Value 658.0m)
FCF Margin = 4.37% (FCF TTM 79.3m / Revenue TTM 1.81b)
Net Margin = -0.58% (Net Income TTM -10.5m / Revenue TTM 1.81b)
Gross Margin = 8.64% ((Revenue TTM 1.81b - Cost of Revenue TTM 1.66b) / Revenue TTM)
Gross Margin QoQ = 7.89% (prev 8.85%)
Tobins Q-Ratio = 4.53 (Enterprise Value 658.0m / Total Assets 145.2m)
Interest Expense / Debt = unknown (Interest Expense 83.0k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -7.84m (EBIT -9.93m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.36 (Total Current Assets 124.7m / Total Current Liabilities 91.6m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 8.81 (negative EBITDA) (Net Debt -72.4m / EBITDA -8.21m)
Debt / FCF = -0.91 (Net Debt -72.4m / FCF TTM 79.3m)
Total Stockholder Equity = 41.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.51% (Net Income -10.5m / Total Assets 145.2m)
RoE = -25.15% (Net Income TTM -10.5m / Total Stockholder Equity 41.9m)
RoCE = -18.52% (EBIT -9.93m / Capital Employed (Total Assets 145.2m - Current Liab 91.6m))
RoIC = -18.70% (negative operating profit) (NOPAT -7.84m / Invested Capital 41.9m)
WACC = 9.44% (E(749.8m)/V(749.8m) * Re(9.44%) + (debt-free company))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.91%
[DCF Debug] Terminal Value 76.73% ; FCFF base≈66.1m ; Y1≈81.5m ; Y5≈138.9m
Fair Price DCF = 8.91 (EV 1.81b - Net Debt -72.4m = Equity 1.89b / Shares 211.8m; r=9.44% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.57 | EPS CAGR: 11.10% | SUE: 0.86 | # QB: 1
Revenue Correlation: 96.35 | Revenue CAGR: 90.74% | SUE: 1.73 | # QB: 11
EPS next Quarter (2026-03-31): EPS=-0.01 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.00 | Chg30d=+0.006 | Revisions Net=-1 | Growth EPS=+91.3% | Growth Revenue=+20.7%